Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a Healthcare company (Medical - Devices) with a market capitalization of $2.1B. The Maz Rating grades it against the other companies in its sector.
Establishment Labs Holdings Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $69.51, Establishment Labs Holdings Inc. trades at 7.8x sales and 135.6x book value. Over the last twelve months it generated about $264M of revenue and a net loss of $38M. It runs a gross margin of 70.2%, an operating margin of -6.6% and a net margin of -14.6%. It shows return on equity of -203.6%, return on invested capital of -5.0% and a free cash flow yield of -1.1%. On the balance sheet: a debt-to-equity ratio of 17.28 and a current ratio of 3.57. Over the past 52 weeks the share price ranged from $53.16 to $97.59, with a beta of 1.00.
Establishment Labs Holdings Inc. does not currently pay a dividend.
14 Wall Street analyst ratings cover the stock: 13 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.